Time to raise the bar: Transition rate of phase 1 programs on anticancer drugs.
Zhao S, Wang D, Zhao H, Gong J, Zhang J, Fang W, Ma F, Xu B, Li J, Hu X, Ba Y, Chen X, Yang Z, Shen L, Jiang J, Zhang L; Chinese Phase 1 Oncology Trial Consortium.
Zhao S, et al. Among authors: li j.
Cancer Cell. 2022 Mar 14;40(3):233-235. doi: 10.1016/j.ccell.2022.01.007. Epub 2022 Feb 24.
Cancer Cell. 2022.
PMID: 35290782
Free article.
No abstract available.